Similarly, from our clinical DLBCL tissue samples, we found that the mRNA expression of upregulated NCBP1 was positively correlated with high METTL3 expression levels (Fig. 3D). The gene discussed is METTL3; the disease is diffuse large B-cell lymphoma.